Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

TriNetX Joins CERTAINTY Project to Enhance Cancer Immunotherapy

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

TriNetX,-LLC.

More Like This

PR Newswire associated0

TriNetX Achieves Spain's ENS Certification for Rigorous Healthcare Data Security Standards

PR Newswire associated0

TriNetX Named Among the Top 25 Healthcare Software Companies of 2025

PR Newswire associated0

TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics

PR Newswire associated0

TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

ACCESSWIRE associated0

New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg

PR Newswire associated0

TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research

PR Newswire associated0

TriNetX and Fujitsu Launch Joint Venture to Increase Japanese Patients' Access to Life-Changing Medicines

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us